Mutual of America Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.4M | Sell |
22,937
-605
| -3% | -$341K | 0.12% | 155 |
|
|
2026
Q1 | $14M | Sell |
23,542
-1,278
| -5% | -$636K | 0.16% | 105 |
|
|
2025
Q4 | $12.1M | Sell |
24,820
-1,648
| -6% | -$767K | 0.13% | 139 |
|
|
2025
Q3 | $11.1M | Buy |
26,468
+4,036
| +18% | +$1.36M | 0.12% | 163 |
|
|
2025
Q2 | $6.45M | Sell |
22,432
-546
| -2% | -$163K | 0.07% | 323 |
|
|
2025
Q1 | $7.08M | Sell |
22,978
-605
| -3% | -$207K | 0.08% | 271 |
|
|
2024
Q4 | $8.32M | Sell |
23,583
-464
| -2% | -$171K | 0.09% | 231 |
|
|
2024
Q3 | $8.62M | Sell |
24,047
-1,351
| -5% | -$456K | 0.09% | 231 |
|
|
2024
Q2 | $8.09M | Sell |
25,398
-2,603
| -9% | -$689K | 0.09% | 225 |
|
|
2024
Q1 | $6.43M | Sell |
28,001
-980
| -3% | -$221K | 0.07% | 335 |
|
|
2023
Q4 | $6.37M | Sell |
28,981
-1,508
| -5% | -$348K | 0.07% | 311 |
|
|
2023
Q3 | $6.89M | Sell |
30,489
-3,567
| -10% | -$822K | 0.08% | 244 |
|
|
2023
Q2 | $7.52M | Sell |
34,056
-2,605
| -7% | -$577K | 0.09% | 242 |
|
|
2023
Q1 | $8.21M | Sell |
36,661
-769
| -2% | -$190K | 0.1% | 213 |
|
|
2022
Q4 | $10.4M | Buy |
37,430
+870
| +2% | +$220K | 0.13% | 143 |
|
|
2022
Q3 | $7.66M | Sell |
36,560
-1,318
| -3% | -$295K | 0.1% | 209 |
|
|
2022
Q2 | $8.93M | Sell |
37,878
-3,187
| -8% | -$648K | 0.11% | 174 |
|
|
2022
Q1 | $7.37M | Buy |
41,065
+792
| +2% | +$151K | 0.08% | 336 |
|
|
2021
Q4 | $8.7M | Buy |
40,273
+700
| +2% | +$137K | 0.09% | 283 |
|
|
2021
Q3 | $7.3M | Buy |
39,573
+84
| +0.2% | +$16.5K | 0.07% | 330 |
|
|
2021
Q2 | $7.08M | Sell |
39,489
-710
| -2% | -$135K | 0.07% | 348 |
|
|
2021
Q1 | $6.72M | Sell |
40,199
-1,505
| -4% | -$251K | 0.07% | 353 |
|
|
2020
Q4 | $6.33M | Buy |
41,704
+286
| +0.7% | +$37.5K | 0.07% | 350 |
|
|
2020
Q3 | $4.18M | Buy |
41,418
+569
| +1% | +$62.4K | 0.06% | 451 |
|
|
2020
Q2 | $4.94M | Buy |
40,849
+30
| +0.1% | +$3.38K | 0.07% | 364 |
|
|
2020
Q1 | $3.87M | Buy |
40,819
+1,547
| +4% | +$147K | 0.06% | 388 |
|
|
2019
Q4 | $3.46M | Buy |
39,272
+190
| +0.5% | +$16.7K | 0.04% | 635 |
|
|
2019
Q3 | $3.12M | Buy |
39,082
+280
| +0.7% | +$22.5K | 0.04% | 655 |
|
|
2019
Q2 | $3.03M | Buy |
38,802
+399
| +1% | +$37.3K | 0.04% | 680 |
|
|
2019
Q1 | $4.51M | Sell |
38,403
-1,048
| -3% | -$122K | 0.07% | 437 |
|
|
2018
Q4 | $4.3M | Buy |
39,451
+1,491
| +4% | +$173K | 0.07% | 407 |
|
|
2018
Q3 | $4.85M | Sell |
37,960
-427
| -1% | -$52.8K | 0.07% | 425 |
|
|
2018
Q2 | $4.34M | Buy |
38,387
+1,820
| +5% | +$200K | 0.06% | 463 |
|
|
2018
Q1 | $4.11M | Sell |
36,567
-157
| -0.4% | -$19.9K | 0.06% | 491 |
|
|
2017
Q4 | $5.43M | Buy |
36,724
+685
| +2% | +$87.1K | 0.08% | 339 |
|
|
2017
Q3 | $4.22M | Sell |
36,039
-1,195
| -3% | -$153K | 0.07% | 450 |
|
|
2017
Q2 | $4.83M | Buy |
37,234
+566
| +2% | +$70.6K | 0.08% | 356 |
|
|
2017
Q1 | $4.96M | Buy |
36,668
+2,614
| +8% | +$396K | 0.09% | 328 |
|
|
2016
Q4 | $4.88M | Buy |
34,054
+318
| +0.9% | +$40.6K | 0.09% | 304 |
|
|
2016
Q3 | $3.98M | Sell |
33,736
-13
| -0% | -$1.56K | 0.08% | 385 |
|
|
2016
Q2 | $3.58M | Buy |
33,749
+2,420
| +8% | +$270K | 0.08% | 396 |
|
|
2016
Q1 | $3.49M | Buy |
31,329
+699
| +2% | +$88.5K | 0.08% | 375 |
|
|
2015
Q4 | $4.8M | Buy |
30,630
+37
| +0.1% | +$5.39K | 0.11% | 224 |
|
|
2015
Q3 | $4.01M | Buy |
30,593
+640
| +2% | +$103K | 0.1% | 283 |
|
|
2015
Q2 | $5.21M | Sell |
29,953
-639
| -2% | -$115K | 0.11% | 202 |
|
|
2015
Q1 | $5.28M | Buy |
30,592
+659
| +2% | +$100K | 0.11% | 197 |
|
|
2014
Q4 | $3.88M | Buy |
29,933
+272
| +0.9% | +$35.1K | 0.09% | 330 |
|
|
2014
Q3 | $3.82M | Buy |
29,661
+2,372
| +9% | +$245K | 0.09% | 298 |
|
|
2014
Q2 | $2.42M | Sell |
27,289
-2,129
| -7% | -$205K | 0.06% | 585 |
|
|
2014
Q1 | $2.77M | Buy |
29,418
+995
| +4% | +$102K | 0.07% | 501 |
|
|
2013
Q4 | $3.21M | Buy |
28,423
+421
| +2% | +$38K | 0.08% | 390 |
|
|
2013
Q3 | $2.21M | Buy |
28,002
+819
| +3% | +$59.9K | 0.06% | 553 |
|
|
2013
Q2 | $1.79M | Buy |
+27,183
| New | +$1.75M | 0.05% | 616 |
|
Other funds holding UTHR
ACA
JT
Mutual of America Capital Management's UTHR Position: Q2 2026 in Review
Mutual of America Capital Management reduced its United Therapeutics (UTHR) stake by 2.6% in Q2 2026, selling an estimated $341K and leaving 22,937 shares worth $12.4M. The position accounts for 0.12% of the portfolio, ranked #155.
Mutual of America Capital Management first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $14M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Mutual of America Capital Management held 22,937 shares of United Therapeutics worth $12.4M as of Q2 2026.
- Mutual of America Capital Management sold 605 United Therapeutics shares in Q2 2026, an estimated $341K.
- United Therapeutics made up 0.12% of Mutual of America Capital Management's portfolio in Q2 2026, its #155 holding.
- Mutual of America Capital Management first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Mutual of America Capital Management's United Therapeutics position peaked at $14M in Q1 2026.
- 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.